Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1980 2
1982 1
1983 1
1987 1
1988 1
1990 1
1991 2
1993 1
1996 1
1997 1
1998 2
2000 1
2001 1
2003 3
2004 3
2005 9
2006 6
2007 9
2008 9
2009 5
2010 4
2011 5
2012 6
2013 5
2014 9
2015 13
2016 15
2017 9
2018 9
2019 6
2020 17
2021 21
2022 20
2023 16
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
Phenotypes and personalized medicine in the acute respiratory distress syndrome.
Matthay MA, Arabi YM, Siegel ER, Ware LB, Bos LDJ, Sinha P, Beitler JR, Wick KD, Curley MAQ, Constantin JM, Levitt JE, Calfee CS. Matthay MA, et al. Among authors: siegel er. Intensive Care Med. 2020 Dec;46(12):2136-2152. doi: 10.1007/s00134-020-06296-9. Epub 2020 Nov 18. Intensive Care Med. 2020. PMID: 33206201 Free PMC article. Review.
In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma.
Mutlu L, Manavella DD, Bellone S, McNamara B, Harold JA, Mauricio D, Siegel ER, Buza N, Hui P, Hartwich TMP, Yang-Hartwich Y, Demirkiran C, Verzosa MSZ, Altwerger G, Ratner ES, Huang GS, Clark M, Andikyan V, Azodi M, Dottino PR, Schwartz PE, Santin AD. Mutlu L, et al. Among authors: siegel er. Mol Cancer Ther. 2023 Dec 1;22(12):1404-1412. doi: 10.1158/1535-7163.MCT-23-0126. Mol Cancer Ther. 2023. PMID: 37676984
Second-Degree Atrioventricular Block-Reply.
Siegel ER, Salazar JW, Tseng ZH. Siegel ER, et al. JAMA Intern Med. 2021 May 1;181(5):724. doi: 10.1001/jamainternmed.2020.8595. JAMA Intern Med. 2021. PMID: 33555309 No abstract available.
Editor's Note.
Siegel ER. Siegel ER. Inf Serv Use. 2022 May 10;42(1):1. doi: 10.3233/ISU-220156. eCollection 2022. Inf Serv Use. 2022. PMID: 35600118 Free PMC article. No abstract available.
Editor's Note.
Siegel ER. Siegel ER. Inf Serv Use. 2022 Apr 26;41(3-4):191. doi: 10.3233/ISU-210132. eCollection 2021. Inf Serv Use. 2022. PMID: 35602572 Free PMC article. No abstract available.
High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma.
Cheng Y, Sun F, Alapat DV, Wanchai V, Mery D, Guo W, Cao H, Zhu Y, Ashby C, Bauer MA, Nookaew I, Siegel ER, Ying J, Chen JR, Gai D, Peng B, Xu H, Bailey C, Al Hadidi S, Schinke C, Thanendrarajan S, Zangari M, Chesi M, Bergsagel PL, van Rhee F, Janz S, Tricot G, Shaughnessy JD Jr, Zhan F. Cheng Y, et al. Among authors: siegel er. Cell Rep Med. 2023 Oct 17;4(10):101214. doi: 10.1016/j.xcrm.2023.101214. Epub 2023 Oct 3. Cell Rep Med. 2023. PMID: 37794587 Free PMC article.
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Bellone S, Jeong K, Halle MK, Krakstad C, McNamara B, Greenman M, Mutlu L, Demirkiran C, Hartwich TMP, Yang-Hartwich Y, Zipponi M, Buza N, Hui P, Raspagliesi F, Lopez S, Paolini B, Milione M, Perrone E, Scambia G, Altwerger G, Ravaggi A, Bignotti E, Huang GS, Andikyan V, Clark M, Ratner E, Azodi M, Schwartz PE, Quick CM, Angioli R, Terranova C, Zaidi S, Nandi S, Alexandrov LB, Siegel ER, Choi J, Schlessinger J, Santin AD. Bellone S, et al. Among authors: siegel er. Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2321898121. doi: 10.1073/pnas.2321898121. Epub 2024 Apr 16. Proc Natl Acad Sci U S A. 2024. PMID: 38625939
A gene signature can predict risk of MGUS progressing to multiple myeloma.
Sun F, Cheng Y, Ying J, Mery D, Al Hadidi S, Wanchai V, Siegel ER, Xu H, Gai D, Ashby TC, Bailey C, Chen JR, Schinke C, Thanendrarajan S, Zangari M, Janz S, Barlogie B, Van Rhee F, Tricot G, Shaughnessy JD Jr, Zhan F. Sun F, et al. Among authors: siegel er. J Hematol Oncol. 2023 Jun 29;16(1):70. doi: 10.1186/s13045-023-01472-y. J Hematol Oncol. 2023. PMID: 37386588 Free PMC article.
Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
Sheth SS, Oh JE, Bellone S, Siegel ER, Greenman M, Mutlu L, McNamara B, Pathy S, Clark M, Azodi M, Altwerger G, Andikyan V, Huang G, Ratner E, Kim DJ, Iwasaki A, Levi AW, Buza N, Hui P, Flaherty S, Schwartz PE, Santin AD. Sheth SS, et al. Among authors: siegel er. Clin Cancer Res. 2024 May 1;30(9):1768-1777. doi: 10.1158/1078-0432.CCR-23-3639. Clin Cancer Res. 2024. PMID: 38592381 Clinical Trial.
A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation.
Guo W, Strouse C, Mery D, Siegel ER, Munshi MN, Ashby TC, Cheng Y, Sun F, Wanchai V, Zhang Z, Bailey C, Alapat DV, Peng H, Al Hadidi S, Thanendrarajan S, Schinke C, Zangari M, van Rhee F, Tricot G, Shaughnessy JD Jr, Zhan F. Guo W, et al. Among authors: siegel er. Cancers (Basel). 2024 Mar 11;16(6):1116. doi: 10.3390/cancers16061116. Cancers (Basel). 2024. PMID: 38539451 Free PMC article.
208 results